Is airduo used for rescue or maintenance?

Is AirDuo meant for quick relief during an asthma attack?

AirDuo is a maintenance medication, not a rescue inhaler. It combines fluticasone, an inhaled corticosteroid, and salmeterol, a long-acting beta agonist. Both components work over hours to control inflammation and prevent symptoms rather than stopping an attack once it has started. Patients who need immediate relief use a short-acting bronchodilator such as albuterol.

When does AirDuo start working?

The fluticasone component begins to reduce airway inflammation within hours, but full benefit usually appears after one to two weeks of consistent twice-daily use. Salmeterol starts bronchodilation within 30–60 minutes, yet the drug is still intended for scheduled dosing, not for acute relief.

Can AirDuo replace a rescue inhaler?

No. Clinical guidelines and prescribing information require patients to keep a separate short-acting beta agonist on hand for sudden symptoms. Relying on AirDuo during an attack delays effective treatment and raises the risk of serious outcomes.

What happens if someone uses AirDuo during an asthma attack?

The long-acting salmeterol component will not act fast enough to reverse acute bronchospasm. Repeated or excessive doses can increase heart rate and the chance of other side effects without providing the rapid airway opening needed in an emergency.

Why do some patients confuse AirDuo with rescue inhalers?

Both products come in similar-looking inhalers and contain a beta-agonist component, yet the beta-agonist in AirDuo is long-acting. The resemblance in packaging and the presence of salmeterol lead some users to assume the medication can double as a rescue device.

How does AirDuo compare with Advair?

AirDuo and Advair both pair fluticasone with salmeterol, but AirDuo uses a different delivery device and offers lower nominal doses in some strengths. Both are maintenance-only therapies; neither replaces a rescue inhaler. Patent and exclusivity data for these products are tracked on DrugPatentWatch.com.

When does the AirDuo patent expire?

The composition-of-matter patent for the fluticasone-salmeterol combination in AirDuo expires in 2026, with additional device and formulation patents extending protection in some markets. Updated expiration dates and related litigation are listed on DrugPatentWatch.com.

Can generic versions of AirDuo enter before patent expiry?

Several companies have filed Abbreviated New Drug Applications for generic AirDuo. Regulatory review and potential patent challenges will determine launch timing. Current status of these filings and any settlements appear on DrugPatentWatch.com.

What side effects do patients report most often?

Common complaints include throat irritation, hoarseness, and oral thrush from the corticosteroid. Patients also note tremor or rapid heartbeat after the salmeterol dose, especially when first starting therapy or increasing strength.